Skip to main content
Ipsen logo

Ipsen — Investor Relations & Filings

Ticker · IPN ISIN · FR0010259150 LEI · 549300M6SGDPB4Z94P11 PA Manufacturing
Filings indexed 1,382 across all filing types
Latest filing 2026-05-13 Board/Management Inform…
Country FR France
Listing PA IPN

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. The company develops and commercializes transformative medicines to address high unmet medical needs in three key therapeutic areas: oncology, rare diseases, and neuroscience. By leveraging its specialized expertise and strategic partnerships, Ipsen aims to accelerate the development of new therapies and improve health outcomes for patients worldwide. Its strategy is centered on advancing science with purpose to bring innovative treatments from research and development to the market.

Recent filings

Filing Released Lang Actions
Ipsen S.A. – Evolution de la composition du Conseil d’administration
Board/Management Information Classification · 88% confidence The document is a press release titled “Evolution de la composition du Conseil d'administration,” announcing the resignation of a board member and interim appointments to the Audit and Remuneration Committees. It clearly relates to changes in the company’s board of directors. This aligns with the definition of Board/Management Information (MANG).
2026-05-13 French
Ipsen S.A. – Evolution of the composition of the Board of Directors
Board/Management Information Classification · 91% confidence The document is a press release announcing the resignation of a board member and interim appointments to board committees. There is no financial data or detailed report; it is an announcement of board composition changes. This fits the definition of Board/Management Information (Code: MANG).
2026-05-13 English
Assemblée Générale Annuelle d’Ipsen S.A. du 13 mai 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 90% confidence The document is a press release dated May 13, 2026, announcing the outcome of Ipsen’s Annual General Meeting – specifically that all 19 resolutions were adopted, including dividend approval, board renewals, and bylaw amendments. It provides official voting results from an AGM. This fits the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2026-05-13 French
Annual General Meeting of Ipsen S.A. held on 13 May 2026
Declaration of Voting Results & Voting Rights Announcements Classification · 85% confidence The document is a press release announcing the outcome of the Annual General Meeting of Ipsen S.A. held on May 13, 2026. It reports the adoption of shareholders’ resolutions (including dividend payment approval and board member renewals) and refers to the results of votes. This clearly corresponds to a Declaration of Voting Results & Voting Rights Announcement, not the full AGM materials or a financial report.
2026-05-13 English
Ipsen enregistre une forte croissance de ses ventes au premier trimestre 2026 et confirme ses objectifs annuels
Earnings Release Classification · 92% confidence The document is an Ipsen press release dated 23 April 2026 announcing first‐quarter 2026 sales results, segment performance tables, 2026 guidance, R&D pipeline updates, and details of a conference call. It is an initial public announcement of quarterly financial results, matching the definition of an Earnings Release. Q1 2026
2026-04-23 French
Ipsen delivers strong sales in the first quarter of 2026 and confirms its full-year guidance
Earnings Release Classification · 95% confidence The document is a press release dated 23 April 2026 from Ipsen presenting its first-quarter 2026 sales results, key performance highlights, full-year guidance confirmation, pipeline updates, and conference call details. It provides initial quarterly financial metrics (sales by segment and geography) and guidance rather than a full interim report with complete financial statements. This matches the definition of an Earnings Release (ER) – an initial announcement of quarterly/periodical financial results. Q1 2026
2026-04-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.